Overview
Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals as well as active pharmaceutical ingredients, combining our trusted expertise with continuous innovation. We have an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by us are used to treat cancer, respiratory diseases and neurological diseases, among others. Across our global footprint, we have six production sites in Finland and three R&D centres in Finland, Cambridge UK and Cambridge, MA, USA. In 2025 our net sales amounted to EUR 1,890 million, and we employ about 4,000 professionals worldwide in 35 countries, dedicated to building well-being.